Biologics Regulatory Affairs Consultant in India

Your Trusted Partner for Biologics Regulatory Affairs Consulting in India. Expert Support for Biologics Registration, Compliance, and Lifecycle Management in India.

Services We Offer

Regulatory Affairs Consulting for Biologics in India

Artixio provides regulatory affairs consulting services for biologics companies looking to operate in the Indian market. We support the registration and lifecycle management of biosimilars, monoclonal antibodies, vaccines, and advanced therapies like cell and gene products.

Our team works closely with clients to prepare regulatory submissions, manage communication with CDSCO, and handle updates across development and post-approval phases. With strong familiarity with India’s biologics guidelines, we help companies stay aligned with local expectations and avoid delays.

Biologics Regulatory Authorities in India:

Regulatory Body	Role
Central Drugs Standard Control Organization (CDSCO)	Main regulatory authority responsible for approval of biologics, including clinical trials, import, manufacture, and marketing.
Drug Controller General of India (DCGI)	Head of CDSCO; grants approval for biologics, biosimilars, vaccines, and oversees regulatory decisions.
Review Committee on Genetic Manipulation (RCGM)	Reviews preclinical data and grants approval for research involving GMOs and biologics at the research stage.

Full Regulatory Support for Product Launch and Market Entry in India

Why Artixio for Biologics Regulatory Affairs in India

FAQs

What types of biologics does Artixio support for regulatory approval in India?

We support a wide range of biologics including biosimilars, monoclonal antibodies (mAbs), therapeutic proteins, gene and cell therapies, vaccines, and recombinant products for CDSCO, RCGM, and GEAC submissions.

Do I need approvals from multiple authorities for biologics in India?

Yes. Depending on the product type, you may need approvals from CDSCO (for market authorization), RCGM (for research involving GMOs), and GEAC (for environmental clearance, especially for recombinant biologics).

How long does it take to get a biologic approved in India?

Timelines vary based on product type and data availability. Typically, approval may take 6–12 months for biosimilars with prior global approval. For novel biologics or gene therapies, timelines may be longer due to preclinical and clinical requirements.